C4 Therapeutics Announces World-class Scientific Advisory Board with Expertise in Therapeutics and the Ubiquitin-proteasome System
CAMBRIDGE, Mass. – C4 Therapeutics (C4T) today announced Ken Anderson, M.D., Nathanael Gray, Ph. D., Christopher Kirk, Ph. D. and Eric Fischer, Ph.